The Myeloproliferative Neoplasms Channel is supported with funding from Takeda (Gold) and Kartos Therapeutics, Inc. (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
MPN Workshop of the Carolinas 2024 | Key takeaways from a panel discussion on interferon in MPNs: considering combination strategies
In this video, Lindsay Rein, MD, Duke University Medical Center, Durham, NC, briefly discusses the key take-home message from a panel discussion on interferons in myeloproliferative neoplasms (MPNs), expressing her enthusiasm at the idea of developing interferon-based combination strategies to improve the outcomes of patients. This interview took place at the 1st Annual MPN Workshop of the Carolinas in Asheville, NC.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
Consultancy: Abbvie, Novartis, Sumitomo, Sobi, Morphsys, Incyte.
